CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R]-CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R]-一抗检测抗体

: CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R]

CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R]

联系购买
分享到：

中文名称：: CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R]

英文名称：: CA19-9/Sialyl Lewisa (GI Tumor Marker) Recombinant Rabbit Monoclonal Antibody [Clone CA19.9/1390R]

规格：: 0.02 mg (With BSA & Azide at 0.2mg/mL)|0.1 mg (With BSA & Azide at 0.2mg/mL)|0.1 mg (Without BSA & Azide at 1mg/mL)|5x0.1 mg (With BSA & Azide at 0.2mg/mL)|5x0.1 mg (Without BSA & Azide at 1mg/mL)

保存建议：: Antibody without azide : Store at -20°C to -80°C . Non Hazardous . No MSDS required.

应用：: IHC (Immunohistochemistry), IF (Immunofluorescence), FCM/FACS (Flow Cytometry)

其他：: 克隆性:Monoclonal
同型:IgG
克隆号:[CA19.9/1390R]
特异性:CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
纯度:N/A
形式：1.0mg/ml. of Ab purified by Protein A column. Prepared in 10mM PBS.
浓度：N/A